These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20334539)

  • 1. Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing.
    DiNunzio JC; Hughey JR; Brough C; Miller DA; Williams RO; McGinity JW
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1064-78. PubMed ID: 20334539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.
    Park YJ; Xuan JJ; Oh DH; Balakrishnan P; Yang HJ; Yeo WH; Lee MK; Choi HG; Yong CS
    Arch Pharm Res; 2010 Aug; 33(8):1217-25. PubMed ID: 20803125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
    DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
    Eur J Pharm Sci; 2010 Jun; 40(3):179-87. PubMed ID: 20230894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusion processing of itraconazole solid dispersions by kinetisol dispersing: a comparative study to hot melt extrusion.
    DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
    J Pharm Sci; 2010 Mar; 99(3):1239-53. PubMed ID: 19681106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
    Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
    J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole.
    DiNunzio JC; Miller DA; Yang W; McGinity JW; Williams RO
    Mol Pharm; 2008; 5(6):968-80. PubMed ID: 19434851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Polyvinyl Alcohol as a Solubility-Enhancing Polymer for Poorly Water Soluble Drug Delivery (Part 1).
    Brough C; Miller DA; Keen JM; Kucera SA; Lubda D; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):167-79. PubMed ID: 26637232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Itraconazole Tablets Containing Viscous KinetiSol Solid Dispersions: In Vitro and In Vivo Analysis in Dogs.
    Keen JM; LaFountaine JS; Hughey JR; Miller DA; McGinity JW
    AAPS PharmSciTech; 2018 Jul; 19(5):1998-2008. PubMed ID: 29192405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.
    Lang B; Liu S; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2016; 42(3):429-45. PubMed ID: 26355819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
    Mou D; Chen H; Wan J; Xu H; Yang X
    Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability.
    Miller MA; DiNunzio J; Matteucci ME; Ludher BS; Williams RO; Johnston KP
    Drug Dev Ind Pharm; 2012 May; 38(5):557-70. PubMed ID: 21961961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Polyvinyl Alcohol as a Solubility Enhancing Polymer for Poorly Water-Soluble Drug Delivery (Part 2).
    Brough C; Miller DA; Ellenberger D; Lubda D; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):180-90. PubMed ID: 26863889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization.
    Ye G; Wang S; Heng PW; Chen L; Wang C
    Int J Pharm; 2007 Jun; 337(1-2):80-7. PubMed ID: 17241757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucoadhesive amorphous solid dispersions for sustained release of poorly water soluble drugs.
    LaFountaine JS; Prasad LK; Miller DA; McGinity JW; Williams RO
    Eur J Pharm Biopharm; 2017 Apr; 113():157-167. PubMed ID: 28088635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
    Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
    J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole.
    Wang X; Michoel A; Van den Mooter G
    Int J Pharm; 2005 Oct; 303(1-2):54-61. PubMed ID: 16105723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.
    Yang W; Tam J; Miller DA; Zhou J; McConville JT; Johnston KP; Williams RO
    Int J Pharm; 2008 Sep; 361(1-2):177-88. PubMed ID: 18556158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silymarin-solid dispersions: characterization and influence of preparation methods on dissolution.
    Sonali D; Tejal S; Vaishali T; Tejal G
    Acta Pharm; 2010 Dec; 60(4):427-43. PubMed ID: 21169135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability.
    Lee S; Nam K; Kim MS; Jun SW; Park JS; Woo JS; Hwang SJ
    Arch Pharm Res; 2005 Jul; 28(7):866-74. PubMed ID: 16114503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubility parameter-based screening methods for early-stage formulation development of itraconazole amorphous solid dispersions.
    Piccinni P; Tian Y; McNaughton A; Fraser J; Brown S; Jones DS; Li S; Andrews GP
    J Pharm Pharmacol; 2016 May; 68(5):705-20. PubMed ID: 26864155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.